EUROPEAN ORGANISATION FOR RARE DISEASES has 30 disclosed EU lobbying meetings from 2024-07-23 to 2026-05-18: 6 with the European Commission and 24 with Members of the European Parliament. Source: EU Transparency Register no. 93272076510-87, Commission disclosures and MEP declarations. Methodology
EUROPEAN ORGANISATION FOR RARE DISEASES
EU lobbying footprint — who they meet, and on what.
- Register no.
- 93272076510-87 ↗
- Disclosed meetings
- 30 (6 Commission · 24 MEP)
- Period
- 2024-07-23 → 2026-05-18
Declared fields of interest: Business and industry · Digital economy and society · Employment and social affairs · European neighbourhood policy · Institutional affairs · Justice and fundamental rights · Public health · Regional policy · Research and innovation · Single market · Youth
Lobbying profile
as declared 2026-05-11- Category
- Non-governmental organisations, platforms and networks and similar
- Legal status
- ASSOCIATION
- Declared lobbying cost
- €400,000
- Lobbying FTEs
- 4
- Members
- 3
At a glance
- Health2
- Social1
- Jana Dabbelt2
- Donata Meroni2
- Maya Matthews1
- Karolina Herbout-Borczak1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- Biotech Actsource ↗
- Rare Diseasessource ↗
- Rare Diseasessource ↗
- Rare diseasessource ↗
- Coordination callsource ↗
- Rare Diseasessource ↗
- 2025-10-02ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiAll pressing portfolio topicssource ↗
- 2025-09-29ECMaya Matthews · Head of UnitInvolvement of individual experts, including patients, taking part in joint clinical assessments and scientific consultations under the EU HTA Regulation, as well as capacity-building activities funded by the EU4Healthsource ↗
- 2025-07-15ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiOngoing policy developmentssource ↗
- 2025-03-26ECDonata Meroni · Head of UnitExchange of views on Cross-Border Healthcare and on patient organisations, EURORDIS and ERNssource ↗
- 2025-03-05ECDonata Meroni · Head of UnitExchange of views on the role of patient organizations with the European Reference Networks.source ↗
- European health policysource ↗
- Rare Diseases Weeksource ↗
- Politique de santé de l Union européennesource ↗
- Enfermedades Rarassource ↗
- EU health policies and EU budgetsource ↗
- Rare diseasessource ↗
- Rare Diseases incidence in Europesource ↗
- Rare diseasessource ↗
- Dossier SANT à venirsource ↗
- EU health policysource ↗
- Rare disease policysource ↗
- EU Policy - Rare Diseasessource ↗
- Health policysource ↗
- Rare Diseases in Europesource ↗
- Rare Disease Week 2024source ↗
- European health policysource ↗
- Introductory Meetingsource ↗
- Health policysource ↗
- 2024-07-23ECKarolina Herbout-Borczak · Cabinet of Commissioner Stella KyriakidesMeeting with EURORDIS to discuss the Commission’s actions on rare diseasessource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has EUROPEAN ORGANISATION FOR RARE DISEASES disclosed?
EUROPEAN ORGANISATION FOR RARE DISEASES (EU Transparency Register no. 93272076510-87) appears in 30 disclosed meetings with EU officials and MEPs between 2024-07-23 and 2026-05-18: 6 with the European Commission and 24 with Members of the European Parliament.
What does EUROPEAN ORGANISATION FOR RARE DISEASES lobby on?
EUROPEAN ORGANISATION FOR RARE DISEASES's disclosed EU meetings most often concern Health, Social. Every meeting and its topic is listed with its official source on this page.
Who does EUROPEAN ORGANISATION FOR RARE DISEASES meet in Brussels?
Across its disclosed meetings, EUROPEAN ORGANISATION FOR RARE DISEASES has met Commission officials including Jana Dabbelt, Donata Meroni, Maya Matthews, and MEPs including ANDRIUKAITIS Vytenis Povilas, GONZÁLEZ CASARES Nicolás, BOSSE Stine. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 93272076510-87) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.